Revvity (RVTY) EBITDA Margin (2009 - 2026)
Revvity's (RVTY) quarterly EBITDA Margin came in at 10.67% in Q2 2026, down 19.0% YoY from 13.17% in Q2 2025, and down 26.27% on a QoQ basis from 14.47% in Q4 2025.
Revvity (RVTY) EBITDA Margin (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of EBITDA Margin data on file, last reported at 10.67% in Q2 2026.
- Quarterly EBITDA Margin fell 19.0% year-over-year to 10.67% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 12.41% (down 112.0% YoY) and the FY2025 annual result came in at 12.49%, down 10.0% from the prior year.
- EBITDA Margin eased to 10.67% in Q2 2026, from 14.47% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 29.18% in Q1 2022 to a low of 6.79% in Q1 2024.
- A 5-year average of 15.25% and a median of 12.6% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin slumped 1707 bps — and 2025, when it surged 408 bps.
- Tracing RVTY's EBITDA Margin over 5 years: stood at 15.56% in 2022, then tumbled by 34 bps to 10.32% in 2023, then soared by 58 bps to 16.28% in 2024, then slipped by 11 bps to 14.47% in 2025, then slipped by 26 bps to 10.67% in 2026.
- The last three EBITDA Margin figures came in at 10.67% (Q2 2026), 14.47% (Q4 2025), and 11.72% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Revvity | 12.89 Bn | 12.03 Bn | 387.66 Mn | 10.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 10.67% |
| Dec 28, 2025 | 14.47% |
| Sep 28, 2025 | 11.72% |
| Jun 29, 2025 | 12.60% |
| Mar 30, 2025 | 10.87% |
| Dec 29, 2024 | 16.28% |
| Sep 29, 2024 | 14.35% |
| Jun 30, 2024 | 12.39% |
| Mar 31, 2024 | 6.79% |
| Oct 1, 2023 | 10.32% |
| Jul 2, 2023 | 11.01% |
| Apr 2, 2023 | 11.28% |
| Jan 1, 2023 | 18.55% |
| Oct 2, 2022 | 15.56% |
| Jul 3, 2022 | 25.96% |
| Apr 3, 2022 | 27.20% |
| Jan 2, 2022 | 29.18% |
| Oct 3, 2021 | 22.70% |
| Jul 4, 2021 | 33.82% |
| Apr 4, 2021 | 44.27% |